Therapy (HCV)

Gel Shift Analysis May Measure IFN Response

Published in Hepatitis Weekly, June 9th, 1997

Gel shift technology may be a useful tool for measuring response to interferon therapy in people with hepatitis C virus.

University of Washington researcher Stephen J. Polyak and colleagues found that quasispecies diversity appears to be an independent variable of hepatitis C virus (HCV) quasispecies heterogeneity, and that gel shift technology is an accurate measure of this diversity.

Interferon treatment for patients with HCV disease leads to a positive biochemical response in 40 to 50 percent of cases, and to a sustained response (sustained clearance of HCV RNA) in approximately 15 percent of patients.

"Although the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1997-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry